A collaborative document redaction solution can also help life science companies comply with the European Medicines Agency (EMA) Transparency Policy 70 on the publication of clinical data.
EMA Policy 70 requires life science companies to redact Personal Private Data (PPD) and Personally Identifiable Data (PID) from documents before being published. Companies may also have to remove some Commercially Confidential Information (CCI), as well as giving the EMA a justification table for each CCI redaction.
As a result, life science companies applying to the EMA must redact thousands of existing and new documents to very tight deadlines.
A collaborative document redaction solution makes delivering PPD, PID and CCI redacted documents much easier.